BMRN in the 13F filings
Biomarin Pharmaceutical Inc · CUSIP 09061G101
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 30
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 13 listed it in both
- Shares listed
- 45,640,716
- combined, among listed positions
- Reported value
- $2.6bn
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 13 buyers (opened or added shares) and 22 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -7,621,618.
Managers listing BMRN in Q2 2026
30 of 30 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 4,822,893 shares now+1,255,862
- Viking Global Investors LPexisting position · 7,616,563 shares now+554,486
- Dodge & Coxexisting position · 14,844,930 shares now+283,171
- Schonfeld Strategic Advisors LLCnew position · 103,192 shares now+103,192
- Marshall Wace LLPnew position · 97,300 shares now+97,300
Reductions
- Citadel Advisors LLCexisting position · 1,122,408 shares now-3,390,226
- AQR Capital Management LLCexisting position · 5,699,541 shares now-1,977,000
- Millennium Management LLCexisting position · 2,071,816 shares now-938,492
- Renaissance Technologies LLCexisting position · 451,871 shares now-573,000
- Balyasny Asset Management LLCexisting position · 1,054,613 shares now-308,139
New positions and exits
New (3)
Exited (6)
- Point72 Asset Management LPwas $68m
- Wellington Management Group LLPwas $40m
- Caxton Associates LLPwas $2.8m
- ExodusPoint Capital Management LPwas $2.5m
- Brevan Howard Capital Management LPwas $562k
- Quantbot Technologies LPwas $13k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 14 | $2.3bn | n.a. | n.a. |
| Q3 2013 | 14 | $2.8bn | n.a. | n.a. |
| Q4 2013 | 11 | $2.5bn | n.a. | n.a. |
| Q1 2014 | 8 | $2.1bn | n.a. | n.a. |
| Q2 2014 | 9 | $1.9bn | n.a. | n.a. |
| Q3 2014 | 8 | $2.5bn | n.a. | n.a. |
| Q4 2014 | 12 | $3.3bn | n.a. | n.a. |
| Q1 2015 | 15 | $5.4bn | n.a. | n.a. |
| Q2 2015 | 14 | $6.3bn | n.a. | n.a. |
| Q3 2015 | 20 | $5.1bn | n.a. | n.a. |
| Q4 2015 | 14 | $4.8bn | n.a. | n.a. |
| Q1 2016 | 10 | $3.4bn | n.a. | n.a. |
| Q2 2016 | 11 | $2.7bn | n.a. | n.a. |
| Q3 2016 | 17 | $3.7bn | n.a. | n.a. |
| Q4 2016 | 13 | $3.0bn | n.a. | n.a. |
| Q1 2017 | 11 | $3.2bn | n.a. | n.a. |
| Q2 2017 | 14 | $3.2bn | n.a. | n.a. |
| Q3 2017 | 16 | $3.9bn | n.a. | n.a. |
| Q4 2017 | 16 | $3.8bn | n.a. | n.a. |
| Q1 2018 | 17 | $3.3bn | n.a. | n.a. |
| Q2 2018 | 14 | $3.6bn | n.a. | n.a. |
| Q3 2018 | 14 | $3.6bn | n.a. | n.a. |
| Q4 2018 | 13 | $3.0bn | n.a. | n.a. |
| Q1 2019 | 15 | $3.1bn | n.a. | n.a. |
| Q2 2019 | 19 | $3.0bn | n.a. | n.a. |
| Q3 2019 | 13 | $2.1bn | n.a. | n.a. |
| Q4 2019 | 15 | $3.0bn | n.a. | n.a. |
| Q1 2020 | 14 | $2.5bn | n.a. | n.a. |
| Q2 2020 | 11 | $3.6bn | n.a. | n.a. |
| Q3 2020 | 12 | $3.0bn | n.a. | n.a. |
| Q4 2020 | 12 | $3.7bn | n.a. | n.a. |
| Q1 2021 | 10 | $3.1bn | n.a. | n.a. |
| Q2 2021 | 11 | $3.4bn | n.a. | n.a. |
| Q3 2021 | 14 | $3.0bn | n.a. | n.a. |
| Q4 2021 | 14 | $3.4bn | n.a. | n.a. |
| Q1 2022 | 19 | $3.0bn | n.a. | n.a. |
| Q2 2022 | 21 | $2.9bn | n.a. | n.a. |
| Q3 2022 | 25 | $3.1bn | n.a. | n.a. |
| Q4 2022 | 26 | $4.0bn | n.a. | n.a. |
| Q1 2023 | 20 | $3.3bn | n.a. | n.a. |
| Q2 2023 | 18 | $2.9bn | n.a. | n.a. |
| Q3 2023 | 18 | $2.9bn | n.a. | n.a. |
| Q4 2023 | 22 | $4.1bn | 14 | 8 |
| Q1 2024 | 19 | $3.6bn | 16 | 4 |
| Q2 2024 | 16 | $3.3bn | 10 | 6 |
| Q3 2024 | 16 | $3.0bn | 9 | 8 |
| Q4 2024 | 14 | $3.0bn | 11 | 2 |
| Q1 2025 | 16 | $3.3bn | 12 | 3 |
| Q2 2025 | 16 | $2.5bn | 12 | 5 |
| Q3 2025 | 16 | $2.3bn | 10 | 5 |
| Q4 2025 | 21 | $2.4bn | 24 | 19 |
| Q1 2026 | 15 | $2.6bn | 14 | 26 |
| Q2 2026 | 12 | $2.2bn | 13 | 22 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
BMRN and LLY →BMRN and JNJ →BMRN and VRTX →Choose a stock to compare with BMRN →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own BMRN, latest filings →Back to the 13F Explorer →